LEASE AGREEMENT ---------------Lease Agreement • October 19th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
EARLY TERMINATION; Tenant has the right to terminate the Lease at any time prior to the end of the Term. However, Tenant is responsible for the full payment of the remaining Lease from the date of early termination notice to the end of the 5-year term.
EXHIBIT 1.2 AGENCY AGREEMENT -- UNIT PRIVATE PLACEMENT THIS AGREEMENT dated for reference March 31, 2004, is made BETWEEN CHEMOKINE THERAPEUTICS CORP., 2386 East Mall, Unit 208, Vancouver, British Columbia, V6T 1Z3Agency Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp • British Columbia
EXHIBIT 10.4 EMPLOYMENT AGREEMENT THIS AGREEMENT is made as of the 1st, day of April 2004. BETWEEN: CHEMOKINE THERAPEUTICS CORP., A DELAWARE CORPORATION WITH ITS WHOLLY OWNED SUBSIDIARY CHEMOKINE THERAPEUTICS (BC) CORP. a BC Corporation, having a...Employment Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp
EXHIBIT 10.2 DEVELOPMENT AGREEMENT THIS DEVELOPMENT AGREEMENT is dated January 1, 2003 BETWEEN: GLOBE LABORATORIES INC., a British Columbia Corporation having its registered and records office at 410 - 1333 West Broadway, Vancouver, B.C. V6H 4C1Development Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp • British Columbia
EXHIBIT 10.3 EMPLOYMENT AGREEMENT THIS EMPLOYMENT AGREEMENT is made this 1st day of April 2004 (the "Agreement"), between Chemokine Therapeutics Corp. a Delaware Corporation and its wholly owned subsidiary Chemokine Therapeutics (BC) Corp. a BC...Employment Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp • British Columbia
EXHIBIT 10.14 Confidential RESEARCH AND DEVELOPMENT AGREEMENT BETWEEN Chemokine Therapeutics Corp. 2386 East Mall Suite 208 Vancouver, B.C. V6T 1Z3 Canada AND Procter & Gamble Pharmaceuticals, Inc. 8700 Mason-Montgomery Road Mason, OH 45040-9462 USA...Research and Development Agreement • October 19th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • Ohio
ESCROW AGREEMENTEscrow Agreement • December 17th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
EXHIBIT 10.12 2004 WARRANT AGREEMENT THIS WARRANT AGREEMENT (the "Agreement"), dated as of September 14, 2004, is made and entered into by and between CHEMOKINE THERAPEUTICS CORP., a Delaware corporation (the "Company"), and PHARMACEUTICAL PRODUCT...Warrant Agreement • October 19th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware
CHEMOKINE THERAPEUTICS CORP. INDEMNIFICATION AGREEMENTIndemnification Agreement • April 16th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is effective as of ·, 2007, by and between ______________________ (“Indemnitee”) and Chemokine Therapeutics Corp., a Delaware corporation (the “Company”).
EXHIBIT 1.1 AMENDED AGENCY OFFERING AGREEMENT THIS AGREEMENT dated for reference December 16, 2004 is made BETWEEN CHEMOKINE THERAPEUTICS CORP., 2386 East Mall, Suite 208, University of British Columbia, Vancouver, British Columbia V6T 1Z3Agency Offering Agreement • December 17th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
LEASE AGREEMENT ---------------Lease Agreement • November 26th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
EARLY TERMINATION; Tenant has the right to terminate the Lease at any time prior to the end of the Term. However, Tenant is responsible for the full payment of the remaining Lease from the date of early termination notice to the end of the 5-year term.
EMPLOYMENT AGREEMENTEmployment Agreement • June 4th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware
The Employee is presently employed, or is about to be employed, by the Company on the terms and conditions which are now set forth in this Agreement.
EXHIBIT 10.1 LICENSE AGREEMENT BETWEEN: THE UNIVERSITY OF BRITISH COLUMBIA, a corporation continued under the University Act of British Columbia and having its administrative offices at 2075 Wesbrook Mall, in the City of Vancouver, in the Province of...License Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp • British Columbia
Option and License Agreement OPTION AND LICENSE AGREEMENT THIS OPTION AND LICENSE AGREEMENT (the "Agreement") is entered into as of 15th day of April, 2003 (the "Effective Date"), by and between Chemokine Therapeutics Corp., a Delaware corporation,...Option and License Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp • North Carolina
RECITALS:Loan and Stock Warrant Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp • North Carolina
AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 16th, 2005 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
THIS AMENDED EMPLOYMENT AGREEMENT is made this 10th day of March 2005 (the “Agreement”), between Chemokine Therapeutics Corp. a Delaware Corporation and its wholly owned subsidiary Chemokine Therapeutics (B.C.) Corp. a B.C. Corporation (collectively the “Company”), and David Karp (the “Employee or the Executive”).
April 12, 2005 David Karp Chief Financial Officer Chemokine Therapeutics Corp. Vancouver, BC V6T 1Z3 Canada VIA CAMPUS MAIL Dear Mr. Karp, Re: Amendment to License Agreement between UBC and Chemokine Therapeutics Corporation dated September 22, 1999...License Agreement • April 24th, 2006 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
This letter agreement is to amend the subject of the License. The parties hereby agree to amend the License by making the following changes:
EXTENSION AND AMENDMENT OF SUB-LEASE GERALD McGAVIN BUILDING UNIVERSITY OF BRITISH COLUMBIASub-Lease Extension and Amendment Agreement • January 8th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
PREFERRED STOCK AND LICENSE RESTRUCTURING AGREEMENTPreferred Stock and License Restructuring Agreement • April 24th, 2006 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • Delaware
THIS PREFERRED STOCK AND LICENSE RESTRUCTURING AGREEMENT (this “Agreement”), is made effective as of the 12th day of April, 2006, by and between Chemokine Therapeutics Corp., a Delaware corporation (“Chemokine”), and Pharmaceutical Product Development, Inc., a North Carolina corporation (“PPD”).
EXHIBIT 10.13 AMENDED EMPLOYMENT AGREEMENT AND AMENDED STOCK OPTION AGREEMENT THIS AMENDED EMPLOYMENT AGREEMENT and AMENDED STOCK OPTION AGREEMENT is made this 30th day of September 2004 (the "Agreement"), between Chemokine Therapeutics Corp. a...Employment Agreement • October 19th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
THIS AGREEMENT made as of December 29, 2006. BETWEEN: GLOBE LABORATORIES INC., a company amalgamated under the laws of British Columbia (the “Vendor”) AND: CHEMOKINE THERAPEUTICS (B.C.) CORP., a company incorporated under the laws of British Columbia...Asset Purchase Agreement • January 8th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
THIS AGREEMENT WITNESSES THAT, in consideration of the premises and the covenants and agreements herein contained, the Vendor and the Purchaser agree as follows:
THIS EXECUTIVE SERVICES AGREEMENT (“AGREEMENT”) is made effective the 28th day of June, 2006. JOINTLY BETWEEN: Chemokine Therapeutics Corp. and Chemokine Therapeutics (BC) Corp.Executive Services Agreement • August 10th, 2006 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
PARTIAL ASSIGNMENT OF SUBLEASE GERALD McGAVIN BUILDING UNIVERSITY OF BRITISH COLUMBIAPartial Assignment of Sublease • January 8th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
SUB-LEASESub-Lease • January 8th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
TECHNICAL ENTERPRISE FACILITY 3 SUB-LEASESub-Lease • April 16th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 16th, 2005 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
THIS AMENDED EMPLOYMENT AGREEMENT is made this 10th day of March 2005 (the “Agreement”), between Chemokine Therapeutics Corp. a Delaware Corporation and its wholly owned subsidiary Chemokine Therapeutics (B.C.) Corp. a B.C. Corporation (collectively the “Company”), and Dr. Hassan Salari (the “Employee or the Executive”).
AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 15th, 2005 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
THIS AMENDED EMPLOYMENT AGREEMENT is made this 10th day of March 2005 (the “Agreement”), between Chemokine Therapeutics Corp. a Delaware Corporation and its wholly owned subsidiary Chemokine Therapeutics (B.C.) Corp. a B.C. Corporation (collectively the “Company”), and Dr. Hassan Salari (the “Employee or the Executive”).
April 12, 2005 David Karp Chief Financial Officer Chemokine Therapeuties Corp. Vancouver, BC, V6T 1Z3 Canada VIA CAMPUS MAIL Dear Mr. Karp, Re: Amendment to License Agreement between UBC and Chemokine Therapeutics Corporation dated September 22, 1999...License Agreement • April 26th, 2005 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
This letter agreement is to amend the subject of the License. The parties hereby agree to amend the License by making the following changes:
AGREEMENT RE: EXERCISE OF STOCK WARRANTExercise of Stock Warrant Agreement • August 2nd, 2004 • Chemokine Therapeutics Corp • North Carolina
UBC-CHEMOKINE LICENSE THIRD AMENDMENTUbc-Chemokine License • May 23rd, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
The University and the Licensee are parties to a License Agreement dated September 22, 1999, as amended by an Amendment between the parties dated April 12, 2005 and a Second Amendment between the parties dated January 29, 2007 (the “UBC-Chemokine License”).
RECITALSModification and Waiver Agreement • October 19th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • North Carolina
RECITALSConsulting Agreement • October 19th, 2004 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • North Carolina
AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • March 15th, 2005 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
THIS AMENDED EMPLOYMENT AGREEMENT is made this 10th day of March 2005 (the “Agreement”), between Chemokine Therapeutics Corp. a Delaware Corporation and its wholly owned subsidiary Chemokine Therapeutics (B.C.) Corp. a B.C. Corporation (collectively the “Company”), and David Karp (the “Employee or the Executive”).
AMENDMENT TO EMPLOYMENT AGREEMENTEmployment Agreement • April 7th, 2008 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances)
THIS AMENDMENT TO EMPLOYMENT AGREEMENT is made effective as of the 4th day of December, 2007 (the “Effective Date”) by and among Chemokine Therapeutics Corp., a Delaware corporation (“Parent”) and Dr. Hassan Salari (the “Executive”).
AMENDED EMPLOYMENT AGREEMENTEmployment Agreement • July 6th, 2007 • Chemokine Therapeutics Corp • Biological products, (no disgnostic substances) • British Columbia
Chemokine Therapeutics Corp. a Delaware Corporation and its wholly owned subsidiary Chemokine Therapeutics (BC) Corp. a company incorporated pursuant to the laws of the Province of British Columbia and having a business office at 6190 Agronomy Rd. Suite 405, Vancouver, BC. V6T 1Z3
